 Gout Suppressants
"Gout Suppressants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.
| Descriptor ID |
D006074
|
| MeSH Number(s) |
D27.505.954.329.337
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gout Suppressants".
Below are MeSH descriptors whose meaning is more specific than "Gout Suppressants".
This graph shows the total number of publications written about "Gout Suppressants" by people in this website by year, and whether "Gout Suppressants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2007 | 1 | 2 | 3 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 3 | 1 | 4 | | 2014 | 1 | 1 | 2 | | 2015 | 2 | 0 | 2 | | 2017 | 1 | 0 | 1 | | 2019 | 2 | 2 | 4 | | 2020 | 1 | 2 | 3 | | 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Gout Suppressants" by people in Profiles.
-
Topless RKG, Major TJ, Florez JC, Hirschhorn JN, Cadzow M, Dalbeth N, Stamp LK, Wilcox PL, Reynolds RJ, Cole JB, Merriman TR. The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect. Arthritis Res Ther. 2021 03 04; 23(1):75.
-
Floege J, Johnson RJ. Hyperuricemia and progression of chronic kidney disease: to treat or not to treat? Kidney Int. 2021 01; 99(1):14-16.
-
Kang DH, Sanchez-Lozada LG, Johnson RJ. Allopurinol and Chronic Kidney Disease. N Engl J Med. 2020 Oct 22; 383(17):1687-1688.
-
Maes ML, Saseen JJ, Wright G, Claus LW. Utilization of acute gout prophylaxis in the real world: a retrospective database cohort analysis. Clin Rheumatol. 2021 Mar; 40(3):1017-1026.
-
Kuwabara M, Borghi C, Johnson RJ. Febuxostat and atrial fibrillation. Eur Heart J. 2020 08 07; 41(30):2916-2917.
-
Villa Zapata L, Hansten PD, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin. Drug Saf. 2020 07; 43(7):661-668.
-
Ko J, Kang HJ, Kim DA, Kim MJ, Ryu ES, Lee S, Ryu JH, Roncal C, Johnson RJ, Kang DH. Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding. FASEB J. 2019 12; 33(12):13334-13345.
-
Brigham MD, Radeck LP, Mendonca CM, Lang I, Li JW, Kent JD, LaMoreaux B, Mandell BF, Johnson RJ. Gout Severity in Recipients of Kidney Transplant. Transplant Proc. 2019 Jul - Aug; 51(6):1816-1821.
-
Huang IJ, Liew JW, Morcos MB, Zuo S, Crawford C, Bays AM. Pharmacist-managed titration of urate-lowering therapy to streamline gout management. Rheumatol Int. 2019 Sep; 39(9):1637-1641.
-
Johnson RJ, Choi HK, Yeo AE, Lipsky PE. Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout. Hypertension. 2019 07; 74(1):95-101.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|